Burlington Stores (BURL) 10-Q 22 Nov 22 2023 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information	9 Months Ended
	Oct. 29, 2022 shares
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Oct. 29, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Trading Symbol	BURL
Entity Registrant Name	BURLINGTON STORES, INC.
Entity Central Index Key	0001579298
Current Fiscal Year End Date	--01-28
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding	65,191,267
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	001-36107
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	80-0895227
Entity Address, Address Line One	2006 Route 130 North
Entity Address, City or Town	Burlington
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	08016
City Area Code	609
Local Phone Number	387-7800
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common stock
Security Exchange Name	NYSE
Document Quarterly Report	true
Document Transition Report	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
REVENUES:
Net sales	$ 2,035,927	$ 2,299,610	$ 5,945,459	$ 6,703,089
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Other revenue	$ 4,760	$ 4,431	$ 12,862	$ 10,159
Total revenue	2,040,687	2,304,041	5,958,321	6,713,248
COSTS AND EXPENSES:
Cost of sales	1,198,126	1,347,559	3,546,340	3,869,432
Selling, general and administrative expenses	726,926	759,785	2,092,756	2,126,904
Costs related to debt issuances and amendments		89		3,419
Depreciation and amortization	67,634	64,663	201,908	183,087
Impairment charges - long-lived assets	10,599	1,488	17,556	3,235
Other income - net	(2,828)	(3,055)	(18,833)	(10,267)
Loss on extinguishment of debt		86,362	14,657	117,756
Interest expense	17,412	15,609	47,454	52,710
Total costs and expenses	2,017,869	2,272,500	5,901,838	6,346,276
Income before income tax expense	22,818	31,541	56,483	366,972
Income tax expense	6,035	17,922	11,560	79,769
Net income	$ 16,783	$ 13,619	$ 44,923	$ 287,203
Net income per common share - basic	$ 0.26	$ 0.20	$ 0.68	$ 4.31
Net income per common share - diluted	$ 0.26	$ 0.20	$ 0.68	$ 4.21
Weighted average number of common stock - basic	65,362	66,740	65,815	66,591
Weighted average number of common stock - diluted	65,504	68,205	66,058	68,228

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 16,783	$ 13,619	$ 44,923	$ 287,203
Interest rate derivative contracts:
Net unrealized gain arising during the period	22,402	6,509	35,693	2,251
Net reclassification into earnings during the period	851	2,984	5,772	7,662
Other comprehensive income, net of tax	23,253	9,493	41,465	9,913
Total comprehensive income	$ 40,036	$ 23,112	$ 86,388	$ 297,116

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Oct. 29, 2022	Jul. 30, 2022	Jan. 29, 2022	Oct. 30, 2021	Jul. 31, 2021
Current assets:
Cash and cash equivalents	$ 428,583		$ 1,091,091	$ 1,185,383
Restricted cash and cash equivalents	6,582		6,582	6,582
Accounts receivable—net	80,641		54,089	90,705
Merchandise inventories	1,445,087		1,021,009	1,059,749
Assets held for disposal	7,054		4,358	4,358
Prepaid and other current assets	131,834		370,515	425,288
Total current assets	2,099,781		2,547,644	2,772,065
Property and equipment—net	1,666,523		1,552,237	1,499,780
Operating lease assets	2,951,614		2,638,473	2,653,776
Tradenames	238,000		238,000	238,000
Goodwill	47,064		47,064	47,064
Deferred tax assets	3,643		3,959	4,119
Other assets	94,885		62,136	63,023
Total assets	7,101,510		7,089,513	7,277,827
Current liabilities:
Accounts payable	953,680		1,080,802	1,174,252
Current operating lease liabilities	391,056		358,793	346,167
Other current liabilities	520,145		493,695	544,852
Current maturities of long term debt	13,528		14,357	14,224
Total current liabilities	1,878,409		1,947,647	2,079,495
Long term debt	1,464,563		1,541,102	1,614,645
Long term operating lease liabilities	2,828,574		2,539,420	2,560,663
Other liabilities	68,687		80,904	94,507
Deferred tax liabilities	222,549		220,023	211,710
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $0.0001 par value: authorized: 50,000,000 shares; no shares issued and outstanding
Common stock, $0.0001 par value: Authorized: 500,000,000 shares; Issued: 81,933,895 shares, 81,677,315 shares and 81,605,876 shares, respectively; Outstanding: 65,191,267 shares, 66,491,555 shares and 66,765,122 shares, respectively	7		7	7
Additional paid-in-capital	1,984,821		1,927,554	1,914,086
Accumulated earnings	459,215		414,292	292,656
Accumulated other comprehensive income (loss)	37,024		(4,441)	(13,102)
Treasury stock, at cost	(1,842,339)		(1,576,995)	(1,476,840)
Total stockholders' equity	638,728	$ 633,877	760,417	716,807	$ 675,695
Total liabilities and stockholders' equity	$ 7,101,510		$ 7,089,513	$ 7,277,827

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Oct. 29, 2022	Jan. 29, 2022	Oct. 30, 2021
Statement of Financial Position [Abstract]
Preferred Stock, Par Value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred Stock, Authorized	50,000,000	50,000,000	50,000,000
Preferred Stock, Issued	0	0	0
Preferred Stock, Outstanding	0	0	0
Common Stock, Par Value	$ 0.0001	$ 0.0001	$ 0.0001
Common Stock, Authorized	500,000,000	500,000,000	500,000,000
Common Stock, Shares Issued	81,933,895	81,677,315	81,605,876
Common Stock, Shares Outstanding	65,191,267	66,491,555	66,765,122

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands		9 Months Ended
		Oct. 29, 2022	Oct. 30, 2021
OPERATING ACTIVITIES
Net income		$ 44,923	$ 287,203
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization		201,908	183,087
Impairment charges—long-lived assets		17,556	3,235
Amortization of deferred financing costs		2,731	4,293
Accretion of long term debt instruments		713	650
Deferred income taxes		(12,339)	46,725
Loss on extinguishment of debt		14,657	117,756
Non-cash stock compensation expense	[1]	51,195	53,356
Non-cash lease expense		674	(6,997)
Cash received from landlord allowances		9,799	24,552
Changes in assets and liabilities:
Accounts receivable		(26,801)	(27,223)
Merchandise inventories		(424,078)	(318,961)
Prepaid and other current assets		238,680	(111,135)
Accounts payable		(133,305)	307,684
Other current liabilities		20,163	(31,280)
Other long term assets and long term liabilities		(1,135)	1,332
Other operating activities		4,236	11,530
Net cash provided by operating activities		9,577	608,367
INVESTING ACTIVITIES
Cash paid for property and equipment		(338,979)	(238,468)
Lease acquisition costs		(3,515)	(559)
Proceeds from sale of property and equipment and assets held for sale		23,383	5,746
Net cash (used in) investing activities		(319,111)	(233,281)
FINANCING ACTIVITIES
Proceeds from long term debt-Term B-6 Loans			956,608
Principal payment on long term debt-Convertible Note		(78,236)	(92,289)
Principal payments on long term debt-Secured Note			(323,905)
Purchase of treasury shares		(265,344)	(166,473)
Proceeds from stock option exercises		6,073	31,610
Deferred financing costs			(601)
Other financing activities		(8,256)	(11,110)
Net cash (used in) financing activities		(352,974)	(569,979)
(Decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents		(662,508)	(194,893)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period		1,097,673	1,386,858
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period		435,165	1,191,965
Supplemental disclosure of cash flow information:
Interest paid		36,944	47,373
Income tax (refund) payments - net		(228,107)	$ 129,624
Non-cash investing and financing activities:
Shares issued to repurchase Convertible Notes			151,206
Finance lease modification		(6,042)
Accrued purchases of property and equipment		75,746	$ 50,696
Senior Secured Term B-6 Loans
FINANCING ACTIVITIES
Principal payments on long term debt		$ (7,211)	(2,404)
Senior Secured Term B-5 Loans
FINANCING ACTIVITIES
Principal payments on long term debt			$ (961,415)
[1] The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 29, 2022 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 3.2 million and $ 9.5 million, respectively . For the three and nine month periods ended October 30, 2021 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 3.1 million and $ 9.2 million, respectively .

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 29, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	1. Summary of Significant Accounting Policies Basis of Presentation As of October 29, 2022, Burlington Stores, Inc., a Delaware corporation (collectively with its subsidiaries, the Company), through its indirect subsidiary Burlington Coat Factory Warehouse Corporation (BCFWC), operated 893 retail stores. These unaudited Condensed Consolidated Financial Statements include the accounts of Burlington Stores, Inc. and its subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation. The Condensed Consolidated Financial Statements are unaudited, but in the opinion of management reflect all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of operations for the interim periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 29, 2022 (Fiscal 2021 10-K). The balance sheet at January 29, 2022 presented herein has been derived from the audited Consolidated Financial Statements contained in the Fiscal 2021 10-K. Because the Company’s business is seasonal in nature, the operating results for the three and nine month periods ended October 29, 2022 are not necessarily indicative of results for the fiscal year. Accounting policies followed by the Company are described in Note 1, “Summary of Significant Accounting Policies,” included in Part II, Item 8 of the Fiscal 2021 10-K. Fiscal Year The Company defines its fiscal year as the 52- or 53-week period ending on the Saturday closest to January 31. The current fiscal year ending January 28, 2023 (Fiscal 2022) and the prior fiscal year ended January 29, 2022 (Fiscal 2021) both consist of 52 weeks. Recently Adopted Accounting Standards There were no new accounting standards that had a material impact on the Company’s Condensed Consolidated Financial Statements and notes thereto during the three and nine month periods ended October 29, 2022, and there were no new accounting standards or pronouncements that were issued but not yet effective as of October 29, 2022 that the Company expects to have a material impact on its financial position or results of operations upon becoming effective.

Stockholders_ Equity

Stockholders’ Equity	6 Months Ended
	Jul. 30, 2022
Stockholders' Equity Note [Abstract]
Stockholders’ Equity	2. Stockholders’ Equity Activity for the three and nine month periods ended October 29, 2022 and October 30, 2021 in the Company’s stockholders’ equity is summarized below: (in thousands, except share data) Common Stock Additional Accumulated Accumulated Treasury Stock Shares Amount Capital Earnings (Loss) Income Shares Amount Total Balance at January 29, 2022 81,677,315 $ 7 $ 1,927,554 $ 414,292 $ ( 4,441 ) ( 15,185,760 ) $ ( 1,576,995 ) $ 760,417 Net income — — — 16,174 — — — 16,174 Stock options exercised 41,673 — 4,721 — — — — 4,721 Shares used for tax withholding — — — — — ( 30,090 ) ( 5,673 ) ( 5,673 ) Shares purchased as part of publicly announced program — — — — — ( 512,905 ) ( 99,090 ) ( 99,090 ) Vesting of restricted shares, net of forfeitures of 199 restricted shares 81,832 — — — — — — — Stock based compensation — — 16,705 — — — — 16,705 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 7.4 million — — — — 20,060 — — 20,060 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 1.1 million — — — — 2,842 — — 2,842 Balance at April 30, 2022 81,800,820 7 1,948,980 430,466 18,461 ( 15,728,755 ) ( 1,681,758 ) 716,156 Net income — — — 11,966 — — — 11,966 Stock options exercised 23,088 — 1,230 — — — — 1,230 Shares used for tax withholding — — — — — ( 34,028 ) ( 6,923 ) ( 6,923 ) Shares purchased as part of publicly announced program — — — — — ( 598,278 ) ( 101,035 ) ( 101,035 ) Vesting of restricted shares 83,620 — — — — — — — Stock based compensation — — 17,173 — — — — 17,173 Unrealized losses on interest rate derivative contracts, net of related taxes of $ 2.6 million — — — — ( 6,769 ) — — ( 6,769 ) Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 0.8 million — — — — 2,079 — — 2,079 Balance at July 30, 2022 81,907,528 $ 7 $ 1,967,383 $ 442,432 $ 13,771 ( 16,361,061 ) $ ( 1,789,716 ) $ 633,877 Net income — — — 16,783 — — — 16,783 Stock options exercised 984 — 121 — — — — 121 Shares used for tax withholding — — — — — ( 10,968 ) ( 1,535 ) ( 1,535 ) Shares purchased as part of publicly announced program — — — — — ( 370,599 ) ( 51,088 ) ( 51,088 ) Vesting of restricted shares 25,383 — — — — — — — Stock based compensation — — 17,317 — — — — 17,317 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 8.2 million — — — — 22,402 — — 22,402 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 0.3 million — — — — 851 — — 851 Balance at October 29, 2022 81,933,895 $ 7 $ 1,984,821 $ 459,215 $ 37,024 ( 16,742,628 ) $ ( 1,842,339 ) $ 638,728 (in thousands, except share data) Common Stock Additional Accumulated (Deficit) Accumulated Treasury Stock Shares Amount Capital Earnings Loss Shares Amount Total Balance at January 30, 2021 80,661,453 $ 7 $ 1,809,831 $ ( 11,702 ) $ ( 23,015 ) ( 14,275,122 ) $ ( 1,310,367 ) $ 464,754 Net income — — — 171,030 — — — 171,030 Stock options exercised 181,683 — 16,089 — — — — 16,089 Shares used for tax withholding — — — — — ( 41,768 ) ( 13,083 ) ( 13,083 ) Vesting of restricted shares, net of forfeitures of 883 restricted shares 53,914 — — — — — — — Stock based compensation — — 12,879 — — — — 12,879 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 0.3 million — — — — 825 — — 825 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 0.8 million — — — — 2,159 — — 2,159 Adoption of ASU 2020-06 — — ( 131,916 ) 17,155 — — — ( 114,761 ) Balance at May 1, 2021 80,897,050 7 1,706,883 176,483 ( 20,031 ) ( 14,316,890 ) ( 1,323,450 ) 539,892 Net income — — — 102,554 — — — 102,554 Stock options exercised 139,274 — 12,811 — — — — 12,811 Shares used for tax withholding — — — — — ( 603 ) ( 178 ) ( 178 ) Vesting of restricted shares, net of forfeitures of 1,101 restricted shares 5,645 — — — — — — — Stock based compensation — — 23,180 — — — — 23,180 Unrealized losses on interest rate derivative contracts, net of related taxes of $ 1.9 million — — — — ( 5,083 ) — — ( 5,083 ) Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes of $ 0.9 million — — — — 2,519 — — 2,519 Balance at July 31, 2021 81,041,969 $ 7 $ 1,742,874 $ 279,037 $ ( 22,595 ) ( 14,317,493 ) $ ( 1,323,628 ) $ 675,695 Net income — — — 13,619 — — — 13,619 Stock options exercised 25,479 — 2,709 — — — — 2,709 Shares used for tax withholding — — — — — ( 10,898 ) ( 3,202 ) ( 3,202 ) Shares purchased as part of publicly announced program — — — — — ( 512,363 ) ( 150,010 ) ( 150,010 ) Vesting of restricted shares, net of forfeitures of 382 restricted shares 24,437 — — — — — — — Stock based compensation — — 17,297 — — — — 17,297 Shares issued to redeem Convertible Notes 513,991 — 151,206 — — — — 151,206 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 2.4 million — — — — 6,509 — — 6,509 Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes of $ 1.1 million — — — — 2,984 — — 2,984 Balance at October 30, 2021 81,605,876 $ 7 $ 1,914,086 $ 292,656 $ ( 13,102 ) ( 14,840,754 ) $ ( 1,476,840 ) $ 716,807

Lease Commitments

Lease Commitments	9 Months Ended
	Oct. 29, 2022
Leases [Abstract]
Lease Commitments	3. Lease Commitments The Company’s leases primarily consist of stores, distribution facilities and office space under operating and finance leases that will expire principally during the next 30 years . The leases typically include renewal options at five year intervals and escalation clauses. Lease renewals are only included in the lease liability to the extent that they are reasonably assured of being exercised. Some of the Company’s leases provide for contingent rentals based on a percentage of gross sales. Contingent rentals are not included in the lease liability, and they are recognized as variable lease cost when incurred. The following is a schedule of the Company’s future lease payments: (in thousands) Fiscal Year Operating Finance 2022 (remainder) $ 121,195 $ 1,460 2023 554,017 5,906 2024 521,395 5,733 2025 487,318 3,604 2026 449,970 3,640 2027 411,946 3,640 Thereafter 1,359,967 24,233 Total future minimum lease payments 3,905,808 48,216 Amount representing interest ( 686,178 ) ( 13,830 ) Total lease liabilities 3,219,630 34,386 Less: current portion of lease liabilities ( 391,056 ) ( 3,914 ) Total long term lease liabilities $ 2,828,574 $ 30,472 Weighted average discount rate 4.8 % 6.1 % Weighted average remaining lease term (years) 8.2 12.0 The above schedule excludes approximately $ 394.5 million for 69 stores that the Company has committed to open or relocate but has not yet taken possession of the space. The discount rates used in valuing the Company’s leases are not readily determinable, and are based on the Company’s incremental borrowing rate on a fully collateralized basis. The following is a schedule of net lease costs for the periods indicated: (in thousands) Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Finance lease cost: Amortization of finance lease asset (a) $ 1,052 $ 1,140 $ 3,333 $ 3,414 Interest on lease liabilities (b) 627 768 2,046 2,366 Operating lease cost (c) 132,984 119,858 387,318 346,789 Variable lease cost (c) 52,141 49,445 152,689 142,356 Total lease cost 186,804 171,211 545,386 494,925 Less all rental income (d) ( 1,507 ) ( 1,386 ) ( 4,195 ) ( 4,015 ) Total net rent expense (e) $ 185,297 $ 169,825 $ 541,191 $ 490,910 (a) Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income. (b) Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income. (c) Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income. (d) Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income. (e) Excludes an immaterial amount of short-term lease cost. Supplemental cash flow disclosures related to leases are as follows: (in thousands) Nine Months Ended October 29, 2022 October 30, 2021 Cash paid for amounts included in the measurement of lease liabilities: Cash payments arising from operating lease liabilities (a) $ 387,209 $ 381,006 Cash payments for the principal portion of finance lease liabilities (b) $ 3,517 $ 2,980 Cash payments for the interest portion of finance lease liabilities (a) $ 2,046 $ 2,366 Supplemental non-cash information: Operating lease liabilities arising from obtaining right-of-use assets (c) $ 609,567 $ 440,874 (a) Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows. (b) Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows. (c) Includes additions arising from lease modifications.

Long Term Debt

Long Term Debt	9 Months Ended
	Oct. 29, 2022
Debt Disclosure [Abstract]
Long Term Debt	4. Long Term Debt Long term debt consists of: (in thousands) October 29, January 29, October 30, 2022 2022 2021 Senior secured term loan facility (Term B-6 Loans), LIBOR (with a floor of 0.00 %) plus 2.00 %, matures on June 24, 2028 $ 944,178 $ 950,676 $ 952,841 Convertible senior notes, 2.25 %, matures on April 15, 2025 507,687 572,322 644,627 ABL senior secured revolving facility, SOFR plus spread based on average outstanding balance, matures on December 22, 2026 — — — Finance lease obligations 34,386 43,945 45,039 Unamortized deferred financing costs ( 8,160 ) ( 11,484 ) ( 13,638 ) Total debt 1,478,091 1,555,459 1,628,869 Less: current maturities ( 13,528 ) ( 14,357 ) ( 14,224 ) Long term debt, net of current maturities $ 1,464,563 $ 1,541,102 $ 1,614,645 Term Loan Facility On June 24, 2021, BCFWC entered into Amendment No. 9 (the Ninth Amendment) to the credit agreement, dated February 24, 2011, among BCFWC the guarantors signatory thereto, and JPMorgan Chase Bank, N.A., as administrative agent and as collateral agent, the lenders party thereto, J.P. Morgan Securities LLC and Goldman Sachs Lending Partners LLC, as joint bookrunners, and J.P. Morgan Securities LLC, Goldman Sachs Lending Partners LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Wells Fargo Securities, LLC, as joint arrangers (as amended from time to time, the Term Loan Credit Agreement) governing the senior secured term loan facility (the Term Loan Facility). The Ninth Amendment, among other things, extended the maturity date from November 17, 2024 to June 24, 2028 , and changed the interest rate margins applicable to the Term Loan Facility from 0.75 % to 1.00 %, in the case of prime rate loans, and from 1.75 % to 2.00 %, in the case of LIBOR loans, with a 0.00 % LIBOR floor. This amendment also requires quarterly principal payments of $ 2.4 million. In connection with the execution of the Ninth Amendment, the Company incurred fees of $ 3.3 million, primarily related to legal and placement fees, which were recorded in the line item “Costs related to debt issuances and amendments” in the Company’s Condensed Consolidated Statement of Income. Additionally, the Company recognized a loss on the extinguishment of debt of $ 1.2 million, representing the write-off of unamortized deferred financing costs and original issue discount, which was recorded in the line item “Loss on extinguishment of debt” in the Company’s Condensed Consolidated Statement of Income. The Term Loan Facility is collateralized by a first lien on the Company's leases, real estate and property & equipment and a second lien on the Company's inventory and receivables. Interest rates for the Term Loan Facility are based on: (i) for LIBOR rate loans for any interest period, at a rate per annum equal to the greater of (x) the LIBOR rate, as determined by the Term Loan Facility Administrative Agent, for such interest period multiplied by the Statutory Reserve Rate (as defined in the Term Loan Credit Agreement), and (y) 0.00 % (the Term Loan Adjusted LIBOR Rate), plus an applicable margin; and (ii) for prime rate loans, a rate per annum equal to the highest of (a) the variable annual rate of interest then announced by JPMorgan Chase Bank, N.A. at its head office as its “prime rate,” (b) the federal reserve bank of New York rate in effect on such date plus 0.50 % per annum, and (c) the Term Loan Adjusted LIBOR Rate for the applicable class of term loans for one-month plus 1.00 %, plus, in each case, an applicable margin. At October 29, 2022 and October 30, 2021 , the interest rate related to the Term Loan Facility was 5.1 % and 2.1 %, respectively. Convertible Notes On April 16, 2020, the Company issued $ 805.0 million of its 2.25 % Convertible Senior Notes due 2025 (Convertible Notes). The Convertible Notes are general unsecured obligations of the Company. The Convertible Notes bear interest at a rate of 2.25 % per year, payable semi-annually in cash, in arrears, on April 15 and October 15 of each year, beginning on October 15, 2020 . The Convertible Notes will mature on April 15, 2025 , unless earlier converted, redeemed or repurchased. During the second half of Fiscal 2021, the Company entered into separate, privately negotiated exchange agreements with certain holders of the Convertible Notes. Under the terms of the exchange agreements, the holders exchanged $ 232.7 million in aggregate principal amount of Convertible Notes held by them for a combination of an aggregate of $ 199.8 million in cash and 513,991 shares of the Company's common stock. During the first quarter of Fiscal 2022, the Company entered into separate, privately negotiated exchange agreements with certain holders of the Convertible Notes. Under the terms of the exchange agreements, the holders exchanged $ 64.6 million in aggregate principal amount of Convertible Notes held by them for $ 78.2 million in cash. These exchanges resulted in aggregate pre-tax debt extinguishment charges of $ 14.7 million and $ 86.4 million during the nine month period ended October 29, 2022 and the nine month period ended October 30, 2021, respectively. Prior to the close of business on the business day immediately preceding January 15, 2025, the Convertible Notes will be convertible at the option of the holders only upon the occurrence of certain events and during certain periods. Thereafter, the Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Convertible Notes have an initial conversion rate of 4.5418 shares per $ 1,000 principal amount of Convertible Notes (equivalent to an initial conversion price of approximately $ 220.18 per share of the Company’s common stock), subject to adjustment if certain events occur. The initial conversion price represents a conversion premium of approximately 32.50 % over $ 166.17 per share, the last reported sale price of the Company’s common stock on April 13, 2020 (the pricing date of the offering) on the New York Stock Exchange. During the first quarter of Fiscal 2021, the Company made an irrevocable settlement election for any conversions of the Convertible Notes. Upon conversion, the Company will pay cash for the principal amount. For any excess above principal, the Company will deliver shares of its common stock. The Company may not redeem the Convertible Notes prior to April 15, 2023. On or after April 15, 2023, the Company will be able to redeem for cash all or any portion of the Convertible Notes, at its option, if the last reported sale price of the Company’s common stock is equal to or greater than 130 % of the conversion price for a specified period of time, at a redemption price equal to 100 % of the principal aggregate amount of the Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. Holders of the Convertible Notes may require the Company to repurchase their Convertible Notes upon the occurrence of certain events that constitute a fundamental change under the indenture governing the Convertible Notes at a purchase price equal to 100 % of the principal amount thereof, plus accrued and unpaid interest to, but excluding, the date of repurchase. In connection with certain corporate events or if the Company issues a notice of redemption, it will, under certain circumstances, increase the conversion rate for holders who elect to convert their Convertible Notes in connection with such corporate event or during the relevant redemption period for such Convertible Notes. The effective interest rate is 2.8 %. The Convertible Notes consist of the following components as of the dates indicated: (in thousands) October 29, January 29, October 30, 2022 2022 2021 Principal $ 507,687 $ 572,322 $ 644,627 Unamortized deferred debt costs ( 6,644 ) ( 9,761 ) ( 11,845 ) Net carrying amount $ 501,043 $ 562,561 $ 632,782 Interest expense related to the Convertible Notes consists of the following as of the periods indicated: (in thousands) Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Coupon interest $ 2,854 $ 3,967 $ 8,711 $ 12,988 Amortization of deferred debt costs 647 941 2,065 2,948 Convertible Notes interest expense $ 3,501 $ 4,908 $ 10,776 $ 15,936 Secured Notes On April 16, 2020, BCFWC issued $ 300.0 million of 6.25 % Senior Secured Notes due 2025 (Secured Notes). The Secured Notes were senior, secured obligations of BCFWC, and interest was payable semiannually in cash, in arrears, at a rate of 6.25 % per annum on April 15 and October 15 of each year, beginning on October 15, 2020 . The Secured Notes were guaranteed on a senior secured basis by Burlington Coat Factory Holdings, LLC, Burlington Coat Factory Investments Holdings, Inc. and BCFWC’s subsidiaries that guarantee the loans under the Term Loan Facility. On June 11, 2021, BCFWC redeemed the full $ 300.0 million aggregate principal amount of the Secured Notes. The redemption price of the Secured Notes was $ 323.7 million, plus accrued and unpaid interest to, but not including, the date of redemption. This redemption resulted in a pre-tax debt extinguishment charge of $ 30.2 million in the third quarter of Fiscal 2021. ABL Line of Credit On July 20, 2022, BCFWC entered into a Fourth Amendment to Second Amended and Restated Credit Agreement (the “Amendment”). The Amendment increased the aggregate principal amount of the commitments of its current asset-based lending facility (the ABL Line of Credit) from $ 650.0 million to $ 900.0 million and replaced the LIBOR-based interest rate benchmark provisions with interest rate benchmark provisions based on a term secured overnight financing rate (SOFR) or a daily SOFR rate (in the case of daily SOFR, available for borrowings up to $ 100 million, or up to the full amount of the commitments if the term SOFR rate is not available) . At October 29, 2022 , the Company had $ 850.0 million available under the ABL Line of Credit. There were no borrowings under the ABL Line of Credit during the three and nine month periods ended October 29, 2022. At October 30, 2021 , the Company had $ 541.0 million available under the ABL Line of Credit. There were no borrowings under the ABL Line of Credit during the three and nine month periods ended October 30, 2021 .

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	9 Months Ended
	Oct. 29, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities	5. Derivative Instruments and Hedging Activities The Company accounts for derivatives and hedging activities in accordance with ASC 815, “Derivatives and Hedging” (ASC 815). As required by ASC 815, the Company records all derivatives on the balance sheet at fair value and adjusts to market on a quarterly basis. In addition, to comply with the provisions of ASC 820, “Fair Value Measurements” (ASC 820), credit valuation adjustments, which consider the impact of any credit enhancements to the contracts, are incorporated in the fair values to account for potential nonperformance risk. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered any applicable credit enhancements such as collateral postings, thresholds, mutual puts, and guarantees. In accordance with ASC 820, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio. There is no impact of netting, because the Company has only one derivative. The Company classifies its derivative valuations in Level 2 of the fair value hierarchy. On December 17, 2018, the Company entered into an interest rate swap, which hedged $ 450 million of the variable rate exposure under the Term Loan Facility at a rate of 2.72 %. On June 24, 2021, the Company terminated this previous interest rate swap, and entered into a new interest rate swap, which hedges $ 450 million of the variable rate exposure on the Term Loan Facility at a blended rate of 2.19 %, and is designated as a cash flow hedge. The amount of loss deferred for the previous interest rate swap was $ 26.9 million. The Company is amortizing this amount from accumulated other comprehensive income into interest expense over the original life of the previous interest rate swap, which had an original maturity date of December 29, 2023 . The new interest rate swap had a liability fair value at inception of $ 26.9 million. The Company will accrete this amount into accumulated other comprehensive income as a benefit to interest expense over the life of the new interest rate swap, which has a maturity date of June 24, 2028 . Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. As of October 29, 2022, the Company had the following outstanding interest rate derivative that was designated as a cash flow hedge of interest rate risk: Interest Rate Derivative Number of Notional Aggregate Principal Amount Interest Swap Rate Maturity Date Interest rate swap contract One $ 450.0 million 2.19 % June 24, 2028 Tabular Disclosure The table below presents the fair value of the Company’s derivative financial instruments on a gross basis as well as their classification on the Company’s Condensed Consolidated Balance Sheets: (in thousands) Fair Values of Derivative Instruments October 29, 2022 January 29, 2022 October 30, 2021 Derivatives Designated as Hedging Instruments Balance Fair Balance Fair Balance Fair Interest rate swap contracts Other assets $ 41,687 Other liabilities $ 10,968 Other liabilities $ 20,439 The following table presents the unrealized gains and losses deferred to accumulated other comprehensive income resulting from the Company’s derivative financial instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Interest Rate Derivatives: October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Unrealized gains, before taxes $ 30,599 $ 8,936 $ 48,746 $ 3,096 Income tax benefit ( 8,197 ) ( 2,427 ) ( 13,053 ) ( 845 ) Unrealized gains, net of taxes $ 22,402 $ 6,509 $ 35,693 $ 2,251 The following table presents information about the reclassification of gains and losses from accumulated other comprehensive income into earnings related to the Company’s derivative instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Component of Earnings: October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Interest expense $ 1,162 $ 4,096 $ 7,901 $ 10,519 Income tax benefit ( 311 ) ( 1,112 ) ( 2,129 ) ( 2,857 ) Net reclassification into earnings $ 851 $ 2,984 $ 5,772 $ 7,662 The Company estimates that approximately $ 4.8 million will be reclassified from accumulated other comprehensive income as a reduction to interest expense during the next twelve months.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 29, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	6. Fair Value Measurements The Company accounts for fair value measurements in accordance with ASC 820, which defines fair value, establishes a framework for measurement and expands disclosure about fair value measurements. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price), and classifies the inputs used to measure fair value into the following hierarchy: Level 1: Quoted prices for identical assets or liabilities in active markets. Level 2: Quoted market prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. Level 3: Pricing inputs that are unobservable for the assets and liabilities and include situations where there is little, if any, market activity for the assets and liabilities. The inputs into the determination of fair value require significant management judgment or estimation. The carrying amounts of cash equivalents, accounts receivable and accounts payable approximate fair value due to the short-term nature of these instruments. Refer to Note 5, “Derivative Instruments and Hedging Activities,” for further discussion regarding the fair value of the Company’s interest rate swap contract. Financial Assets The fair values of the Company’s financial assets and the hierarchy of the level of inputs as of October 29, 2022, January 29, 2022 and October 30, 2021 are summarized below: (in thousands) Fair Value Measurements at October 29, January 29, October 30, 2022 2022 2021 Level 1 Cash equivalents (including restricted cash equivalents) $ 92,424 $ 701,638 $ 701,607 Long-lived assets are measured at fair value on a non-recurring basis for purposes of calculating impairment using the fair value hierarchy of ASC 820. The fair value of the Company’s long-lived assets is calculated using a discounted cash-flow model that used level 3 inputs. In calculating future cash flows, the Company makes estimates regarding future operating results and market rent rates, based on its experience and knowledge of market factors in which the retail location is located. Impairment charges on long-lived assets were $ 10.6 million during the third quarter of Fiscal 2022 , related to two owned stores expected to be sold below net carrying value and declines in revenue and operating results for eight stores. Impairment charges on long-lived assets were $ 1.5 million during the third quarter of Fiscal 2021 , primarily related to store-level assets at four stores. Impairment charges on long-lived assets were $ 17.6 million during the nine months ended October 29, 2022 , related to three owned stores expected to be sold below net carrying value, declines in revenue and operating results for eight stores, and unrecoverable fixed assets at two relocating stores. Impairment charges on long-lived assets were $ 3.2 million during the nine months ended October 30, 2021, primarily related to declines in revenues and operating results at certain stores. During the nine months ended October 29, 2022 and the nine months ended October 30, 2021 , the assets impaired had a remaining carrying value after impairments of $ 69.4 million and $ 13.9 million, respectively. Financial Liabilities The fair values of the Company’s financial liabilities are summarized below: (in thousands) October 29, 2022 January 29, 2022 October 30, 2021 Principal Fair Principal Fair Principal Fair Term B-6 Loans $ 949,397 $ 911,421 $ 956,608 $ 955,412 $ 959,011 $ 953,017 Convertible Notes 507,687 513,982 572,322 724,703 644,627 915,048 ABL Line of Credit (a) — — — — — — Total debt (b) $ 1,457,084 $ 1,425,403 $ 1,528,930 $ 1,680,115 $ 1,603,638 $ 1,868,065 (a) To the extent the Company has any outstanding borrowings under the ABL Line of Credit, the fair value would approximate its reported value, because the interest rate is variable and reflects current market rates, due to its short term nature. (b) The table above excludes finance lease obligations, debt discount and deferred debt costs. The fair values presented herein are based on pertinent information available to management as of the respective period end dates. The estimated fair values of the Company’s debt are classified as Level 2 in the fair value hierarchy, and are based on current market quotes received from inactive markets.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 29, 2022
Income Tax Disclosure [Abstract]
Income Taxes	7. Income Taxes Income tax expense was $ 6.0 million during the third quarter of Fiscal 2022 compared with $ 17.9 million during the third quarter of Fiscal 2021. The effective tax rate for the third quarter of Fiscal 2022 was 26.4 % compared with 56.8 % during the third quarter of Fiscal 2021. The higher income tax expense and tax rate in the prior year period is primarily driven by higher pre-tax income and the disallowance of certain debt extinguishment costs related to partial repurchase of the Convertible Notes during the third quarter of Fiscal 2021. Income tax expense was $ 11.6 million during the nine month period ended October 29, 2022 compared with $ 79.8 million during the nine month period ended October 30, 2021. The effective tax rate for the nine month period ended October 29, 2022 was 20.5 % compared with 21.7 % during the nine month period ended October 30, 2021. The decrease in income tax expense in the nine months ended October 29, 2022 was a result of lower pre-tax income. Net deferred taxes are as follows: (in thousands) October 29, January 29, October 30, 2022 2022 2021 Deferred tax asset $ 3,643 $ 3,959 $ 4,119 Deferred tax liability 222,549 220,023 211,710 Net deferred tax liability $ 218,906 $ 216,064 $ 207,591 Net deferred tax assets relate to Puerto Rico deferred balances that have a future net benefit for tax purposes. Net deferred tax liabilities primarily relate to intangible assets and depreciation expense where the Company has a future obligation for tax purposes. As of October 29, 2022 , the Company had a deferred tax asset related to net operating losses of $ 14.6 million, inclusive of $ 14.3 million related to state net operating losses that expire at various dates between 2023 and 2041 , as well as $ 0.3 million related to Puerto Rico net operating losses that will expire in 2025 . As of October 29, 2022 , the Company had a deferred tax asset related to tax credit carry-forwards of $ 7.8 million, inclusive of $ 7.1 million of state tax credit carry-forwards, which will begin to expire in 2023 , and $ 0.7 million of deferred tax assets recorded for Puerto Rico alternative minimum tax credits that have an indefinite life . As of October 29, 2022, January 29, 2022 and October 30, 2021 , valuation allowances amounted to $ 10.6 million, $ 12.9 million and $ 12.1 million, respectively, related to state and Puerto Rico net operating losses and state tax credit carry-forwards. The Company believes that it is more likely than not that this portion of state and Puerto Rico net operating losses and state tax credit carry-forwards will not be realized.

Capital Stock

Capital Stock	9 Months Ended
	Oct. 29, 2022
Capital Stock [Abstract]
Capital Stock	8. Capital Stock Treasury Stock The Company accounts for treasury stock under the cost method. Shares Used to Satisfy Tax Withholding During the nine month period ended October 29, 2022, the Company acquired 75,086 shares of common stock from employees for approximately $ 14.1 million to satisfy their minimum statutory tax withholdings related to the vesting of restricted stock and restricted stock unit awards, which was recorded in the line item “Treasury stock” on the Company’s Condensed Consolidated Balance Sheets, and the line item “Purchase of treasury shares” on the Company’s Condensed Consolidated Statements of Cash Flows. Share Repurchase Program On August 18, 2021, the Company’s Board of Directors authorized the repurchase of up to $ 400.0 million of common stock, which was authorized to be executed through August 2023 . This authorization was completed during the second quarter of Fiscal 2022. On February 16, 2022, the Company's Board of Directors authorized the repurchase of up to $ 500.0 million of common stock, which is authorized to be executed through February 2024 . These repurchase programs are funded using the Company’s available cash and borrowings under the ABL Line of Credit. During the nine month period ended October 29, 2022, the Company repurchased 1,481,782 shares of common stock for $ 251.2 million under these repurchase programs, which was recorded in the line item “Treasury stock” on the Company’s Condensed Consolidated Balance Sheets, and the line item “Purchase of treasury shares” on the Company’s Condensed Consolidated Statements of Cash Flows. As of October 29, 2022, the Company had $ 398.8 million remaining under its share repurchase authorization.

Net Income Per Share

Net Income Per Share	9 Months Ended
	Oct. 29, 2022
Earnings Per Share [Abstract]
Net Income Per Share	9. Net Income Per Share Basic net income per share is calculated by dividing net income by the weighted-average number of common shares outstanding. Diluted net income per share is calculated by dividing net income by the weighted-average number of common shares and potentially dilutive securities outstanding during the period using the treasury stock method for the Company’s stock option, restricted stock and restricted stock unit awards, and the if-converted method for the Convertible Notes. The following table presents the computation of basic and diluted net income per share: (in thousands, except per share data) Three Months Ended Nine Months Ended October 29, October 30, October 29, October 30, 2022 2021 2022 2021 Basic net income per share Net income $ 16,783 $ 13,619 $ 44,923 $ 287,203 Weighted average number of common shares – basic 65,362 66,740 65,815 66,591 Net income per common share – basic $ 0.26 $ 0.20 $ 0.68 $ 4.31 Diluted net income per share Net income $ 16,783 $ 13,619 $ 44,923 $ 287,203 Shares for basic and diluted net income per share: Weighted average number of common shares – basic 65,362 66,740 65,815 66,591 Assumed exercise of stock options and vesting of restricted stock 142 577 243 666 Assumed conversion of convertible debt — 888 — 971 Weighted average number of common shares – diluted 65,504 68,205 66,058 68,228 Net income per common share – diluted $ 0.26 $ 0.20 $ 0.68 $ 4.21 Approximately 1,498,000 and 1,132,000 shares of the Company’s stock-based compensation grants were excluded from diluted net income per share for the three and nine month periods ended October 29, 2022, respectively, since their effect was anti-dilutive. Approximately 242,000 and 144,000 shares related to the Company’s stock-based compensation grants were excluded from diluted net income per share for the three and nine month periods ended October 30, 2021, respectively, since their effect was anti-dilutive. During the three and nine months ended October 29, 2022, respectively , shares of common stock issuable upon conversion of the Convertible Notes have been excluded from the computation of diluted earnings per share as the effect would be anti-dilutive, since the conversion price of $ 220.18 exceeded the average market price of the Company’s common stock during the periods.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Oct. 29, 2022
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	10. Stock-Based Compensation As of October 29, 2022 , there were 6,287,228 shares of common stock available for issuance under the Company’s 2022 Omnibus Incentive Plan. Non-cash stock compensation expense is as follows: (in thousands) Three Months Ended Nine Months Ended October 29, October 30, October 29, October 30, Type of Non-Cash Stock Compensation 2022 2021 2022 2021 Restricted stock and restricted stock unit grants (a) $ 9,736 $ 8,192 $ 28,519 $ 22,132 Stock option grants (a) 4,851 4,815 15,144 13,891 Performance stock unit grants (a) 2,730 4,290 7,532 17,333 Total (b) $ 17,317 $ 17,297 $ 51,195 $ 53,356 (a) Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income. (b) The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 29, 2022 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 3.2 million and $ 9.5 million, respectively . For the three and nine month periods ended October 30, 2021 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 3.1 million and $ 9.2 million, respectively . Stock Options Stock option transactions during the nine month period ended October 29, 2022 are summarized as follows: Number of Weighted Options outstanding, January 29, 2022 1,097,558 $ 181.17 Options granted 326,483 202.09 Options exercised (a) ( 65,745 ) 92.37 Options forfeited ( 30,453 ) 225.28 Options outstanding, October 29, 2022 1,327,843 $ 189.70 (a) Options exercised during the nine month period ended October 29, 2022 had a total intrinsic value of $ 6.4 million . The following table summarizes information about the stock options vested and expected to vest during the contractual term of such options as of October 29, 2022: Options Weighted Weighted Aggregate Options vested and expected to vest 1,327,843 7.0 $ 189.70 $ 9.4 Options exercisable 726,860 5.5 $ 161.97 $ 9.3 The fair value of each stock option granted during the nine month period ended October 29, 2022 was estimated using the Black Scholes option pricing model using the following assumptions: Nine Months Ended October 29, 2022 Risk-free interest rate 1.13 % - 2.78 % Expected volatility 32 % - 34 % Expected life (years) 6.25 Contractual life (years) 10.0 Expected dividend yield 0 % Weighted average grant date fair value of options issued $ 75.64 The expected dividend yield was based on the Company’s expectation of not paying dividends in the near term. To evaluate its volatility factor, the Company uses the historical volatility of its stock price, as well as the historical volatility of the stock price of peer companies that are publicly traded over the expected life of the options. The risk free interest rate was based on the U.S. Treasury rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the awards being valued. For grants issued during the nine month period ended October 29, 2022, the expected life of the options was calculated using the simplified method. The simplified method defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches. This methodology was utilized due to the relatively short length of time the Company’s common stock has been publicly traded. Restricted Stock Prior to May 1, 2019, the Company granted shares of restricted stock. Grants made on and after May 1, 2019 are in the form of restricted stock units. Restricted stock transactions during the nine month period ended October 29, 2022 are summarized as follows: Number of Weighted Non-vested awards outstanding, January 29, 2022 368,158 $ 233.00 Awards granted 247,768 201.96 Awards vested (a) ( 131,261 ) 205.03 Awards forfeited ( 20,429 ) 234.13 Non-vested awards outstanding, October 29, 2022 464,236 224.29 (a) Restricted stock awards vested during the nine month period ended October 29, 2022 had a total intrinsic value of $ 24.9 million . The fair value of each share of restricted stock granted during the nine month period ended October 29, 2022 was based upon the closing price of the Company’s common stock on the grant date. Performance Stock Units The Company grants performance-based restricted stock units to its senior executives. Vesting of the performance stock units granted in Fiscal 2020 and Fiscal 2021 is based on continued service and the achievement of pre-established EBIT margin expansion and sales compounded annual growth rate (CAGR) goals (each weighted equally) over a three-year performance period. Vesting of the performance stock units granted in Fiscal 2022 will be based on continued service and the achievement of pre-established adjusted net income per share growth over a three-year performance period. Based on the Company’s achievement of these goals, each award may be earned up to 200 % of the target award. In the event that actual performance is below threshold, no award will be made. Compensation costs recognized on the performance stock units are adjusted, as applicable, for performance above or below the target specified in the award. Performance stock unit transactions during the nine month period ended October 29, 2022 are summarized as follows: Number of Weighted Non-vested awards outstanding, January 29, 2022 186,436 $ 215.90 Awards granted (a) 105,783 204.38 Awards vested (a) (b) ( 81,440 ) 173.84 Awards forfeited ( 10,094 ) 228.67 Non-vested awards outstanding, October 29, 2022 200,685 226.25 (a) Inclusive of awards distributed in connection with the final settlement of the performance-based stock awards granted in Fiscal 2019. (b) Performance-based stock awards vested during the nine month period ended October 29, 2022 had a total intrinsic value of $ 15.4 million.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 29, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies Legal In the course of business, the Company is party to class or collective actions alleging violations of federal and state wage and hour and other labor statutes, representative claims under the California Private Attorneys’ General Act and various other lawsuits and regulatory proceedings from time to time including, among others, commercial, product, employee, customer, intellectual property, privacy and other claims. Actions against us are in various procedural stages. Many of these proceedings raise factual and legal issues and are subject to uncertainties. While no assurance can be given as to the ultimate outcome of these matters, the Company believes that the final resolution of these actions will not have a material adverse effect on the Company’s results of operations, financial position, liquidity or capital resources. Letters of Credit The Company had letters of credit arrangements with various banks in the aggregate amount of $ 50.0 million, $ 55.4 million and $ 59.0 million as of October 29, 2022, January 29, 2022 and October 30, 2021, respectively. Among these arrangements, as of October 29, 2022, January 29, 2022 and October 30, 2021 , the Company had letters of credit outstanding in the amount of $ 47.4 million, $ 48.4 million and $ 46.8 million, respectively, guaranteeing performance under various insurance contracts and utility agreements. In addition, the Company had outstanding letters of credit arrangements in the amounts of $ 2.6 million, $ 7.1 million and $ 12.3 million at October 29, 2022, January 29, 2022 and October 30, 2021 , respectively, related to certain merchandising agreements. Based on the terms of the agreement governing the ABL Line of Credit, the Company had the ability to enter into letters of credit up to $ 850.0 million, $ 594.6 million and $ 541.0 million as of October 29, 2022, January 29, 2022 and October 30, 2021, respectively. Purchase Commitments The Company had $ 1,157.0 million of purchase commitments related to goods that were not received as of October 29, 2022. Death Benefits In November 2005, the Company entered into agreements with three of the Company’s former executives whereby upon each of their deaths the Company will pay $ 1.0 million to each respective designated beneficiary.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 29, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation As of October 29, 2022, Burlington Stores, Inc., a Delaware corporation (collectively with its subsidiaries, the Company), through its indirect subsidiary Burlington Coat Factory Warehouse Corporation (BCFWC), operated 893 retail stores. These unaudited Condensed Consolidated Financial Statements include the accounts of Burlington Stores, Inc. and its subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation. The Condensed Consolidated Financial Statements are unaudited, but in the opinion of management reflect all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of operations for the interim periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 29, 2022 (Fiscal 2021 10-K). The balance sheet at January 29, 2022 presented herein has been derived from the audited Consolidated Financial Statements contained in the Fiscal 2021 10-K. Because the Company’s business is seasonal in nature, the operating results for the three and nine month periods ended October 29, 2022 are not necessarily indicative of results for the fiscal year. Accounting policies followed by the Company are described in Note 1, “Summary of Significant Accounting Policies,” included in Part II, Item 8 of the Fiscal 2021 10-K.
Fiscal Year	Fiscal Year The Company defines its fiscal year as the 52- or 53-week period ending on the Saturday closest to January 31. The current fiscal year ending January 28, 2023 (Fiscal 2022) and the prior fiscal year ended January 29, 2022 (Fiscal 2021) both consist of 52 weeks.
Recently Adopted Accounting Standards	Recently Adopted Accounting Standards There were no new accounting standards that had a material impact on the Company’s Condensed Consolidated Financial Statements and notes thereto during the three and nine month periods ended October 29, 2022, and there were no new accounting standards or pronouncements that were issued but not yet effective as of October 29, 2022 that the Company expects to have a material impact on its financial position or results of operations upon becoming effective.

Stockholders_ Equity (Tables)

Stockholders’ Equity (Tables)	6 Months Ended
	Jul. 30, 2022
Stockholders' Equity Note [Abstract]
Company's Stockholders Equity	Activity for the three and nine month periods ended October 29, 2022 and October 30, 2021 in the Company’s stockholders’ equity is summarized below: (in thousands, except share data) Common Stock Additional Accumulated Accumulated Treasury Stock Shares Amount Capital Earnings (Loss) Income Shares Amount Total Balance at January 29, 2022 81,677,315 $ 7 $ 1,927,554 $ 414,292 $ ( 4,441 ) ( 15,185,760 ) $ ( 1,576,995 ) $ 760,417 Net income — — — 16,174 — — — 16,174 Stock options exercised 41,673 — 4,721 — — — — 4,721 Shares used for tax withholding — — — — — ( 30,090 ) ( 5,673 ) ( 5,673 ) Shares purchased as part of publicly announced program — — — — — ( 512,905 ) ( 99,090 ) ( 99,090 ) Vesting of restricted shares, net of forfeitures of 199 restricted shares 81,832 — — — — — — — Stock based compensation — — 16,705 — — — — 16,705 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 7.4 million — — — — 20,060 — — 20,060 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 1.1 million — — — — 2,842 — — 2,842 Balance at April 30, 2022 81,800,820 7 1,948,980 430,466 18,461 ( 15,728,755 ) ( 1,681,758 ) 716,156 Net income — — — 11,966 — — — 11,966 Stock options exercised 23,088 — 1,230 — — — — 1,230 Shares used for tax withholding — — — — — ( 34,028 ) ( 6,923 ) ( 6,923 ) Shares purchased as part of publicly announced program — — — — — ( 598,278 ) ( 101,035 ) ( 101,035 ) Vesting of restricted shares 83,620 — — — — — — — Stock based compensation — — 17,173 — — — — 17,173 Unrealized losses on interest rate derivative contracts, net of related taxes of $ 2.6 million — — — — ( 6,769 ) — — ( 6,769 ) Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 0.8 million — — — — 2,079 — — 2,079 Balance at July 30, 2022 81,907,528 $ 7 $ 1,967,383 $ 442,432 $ 13,771 ( 16,361,061 ) $ ( 1,789,716 ) $ 633,877 Net income — — — 16,783 — — — 16,783 Stock options exercised 984 — 121 — — — — 121 Shares used for tax withholding — — — — — ( 10,968 ) ( 1,535 ) ( 1,535 ) Shares purchased as part of publicly announced program — — — — — ( 370,599 ) ( 51,088 ) ( 51,088 ) Vesting of restricted shares 25,383 — — — — — — — Stock based compensation — — 17,317 — — — — 17,317 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 8.2 million — — — — 22,402 — — 22,402 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 0.3 million — — — — 851 — — 851 Balance at October 29, 2022 81,933,895 $ 7 $ 1,984,821 $ 459,215 $ 37,024 ( 16,742,628 ) $ ( 1,842,339 ) $ 638,728 (in thousands, except share data) Common Stock Additional Accumulated (Deficit) Accumulated Treasury Stock Shares Amount Capital Earnings Loss Shares Amount Total Balance at January 30, 2021 80,661,453 $ 7 $ 1,809,831 $ ( 11,702 ) $ ( 23,015 ) ( 14,275,122 ) $ ( 1,310,367 ) $ 464,754 Net income — — — 171,030 — — — 171,030 Stock options exercised 181,683 — 16,089 — — — — 16,089 Shares used for tax withholding — — — — — ( 41,768 ) ( 13,083 ) ( 13,083 ) Vesting of restricted shares, net of forfeitures of 883 restricted shares 53,914 — — — — — — — Stock based compensation — — 12,879 — — — — 12,879 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 0.3 million — — — — 825 — — 825 Amount reclassified from accumulated other comprehensive income into earnings, net of related taxes of $ 0.8 million — — — — 2,159 — — 2,159 Adoption of ASU 2020-06 — — ( 131,916 ) 17,155 — — — ( 114,761 ) Balance at May 1, 2021 80,897,050 7 1,706,883 176,483 ( 20,031 ) ( 14,316,890 ) ( 1,323,450 ) 539,892 Net income — — — 102,554 — — — 102,554 Stock options exercised 139,274 — 12,811 — — — — 12,811 Shares used for tax withholding — — — — — ( 603 ) ( 178 ) ( 178 ) Vesting of restricted shares, net of forfeitures of 1,101 restricted shares 5,645 — — — — — — — Stock based compensation — — 23,180 — — — — 23,180 Unrealized losses on interest rate derivative contracts, net of related taxes of $ 1.9 million — — — — ( 5,083 ) — — ( 5,083 ) Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes of $ 0.9 million — — — — 2,519 — — 2,519 Balance at July 31, 2021 81,041,969 $ 7 $ 1,742,874 $ 279,037 $ ( 22,595 ) ( 14,317,493 ) $ ( 1,323,628 ) $ 675,695 Net income — — — 13,619 — — — 13,619 Stock options exercised 25,479 — 2,709 — — — — 2,709 Shares used for tax withholding — — — — — ( 10,898 ) ( 3,202 ) ( 3,202 ) Shares purchased as part of publicly announced program — — — — — ( 512,363 ) ( 150,010 ) ( 150,010 ) Vesting of restricted shares, net of forfeitures of 382 restricted shares 24,437 — — — — — — — Stock based compensation — — 17,297 — — — — 17,297 Shares issued to redeem Convertible Notes 513,991 — 151,206 — — — — 151,206 Unrealized gains on interest rate derivative contracts, net of related taxes of $ 2.4 million — — — — 6,509 — — 6,509 Amount reclassified from accumulated other comprehensive loss into earnings, net of related taxes of $ 1.1 million — — — — 2,984 — — 2,984 Balance at October 30, 2021 81,605,876 $ 7 $ 1,914,086 $ 292,656 $ ( 13,102 ) ( 14,840,754 ) $ ( 1,476,840 ) $ 716,807

Lease Commitments (Tables)

Lease Commitments (Tables)	9 Months Ended
	Oct. 29, 2022
Leases [Abstract]
Future Lease Payments	The following is a schedule of the Company’s future lease payments: (in thousands) Fiscal Year Operating Finance 2022 (remainder) $ 121,195 $ 1,460 2023 554,017 5,906 2024 521,395 5,733 2025 487,318 3,604 2026 449,970 3,640 2027 411,946 3,640 Thereafter 1,359,967 24,233 Total future minimum lease payments 3,905,808 48,216 Amount representing interest ( 686,178 ) ( 13,830 ) Total lease liabilities 3,219,630 34,386 Less: current portion of lease liabilities ( 391,056 ) ( 3,914 ) Total long term lease liabilities $ 2,828,574 $ 30,472 Weighted average discount rate 4.8 % 6.1 % Weighted average remaining lease term (years) 8.2 12.0
Schedule of Net Lease Costs	The following is a schedule of net lease costs for the periods indicated: (in thousands) Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Finance lease cost: Amortization of finance lease asset (a) $ 1,052 $ 1,140 $ 3,333 $ 3,414 Interest on lease liabilities (b) 627 768 2,046 2,366 Operating lease cost (c) 132,984 119,858 387,318 346,789 Variable lease cost (c) 52,141 49,445 152,689 142,356 Total lease cost 186,804 171,211 545,386 494,925 Less all rental income (d) ( 1,507 ) ( 1,386 ) ( 4,195 ) ( 4,015 ) Total net rent expense (e) $ 185,297 $ 169,825 $ 541,191 $ 490,910 (a) Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income. (b) Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income. (c) Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income. (d) Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income. (e) Excludes an immaterial amount of short-term lease cost.
Schedule of Supplemental Cash Flow Disclosures Related to Leases	Supplemental cash flow disclosures related to leases are as follows: (in thousands) Nine Months Ended October 29, 2022 October 30, 2021 Cash paid for amounts included in the measurement of lease liabilities: Cash payments arising from operating lease liabilities (a) $ 387,209 $ 381,006 Cash payments for the principal portion of finance lease liabilities (b) $ 3,517 $ 2,980 Cash payments for the interest portion of finance lease liabilities (a) $ 2,046 $ 2,366 Supplemental non-cash information: Operating lease liabilities arising from obtaining right-of-use assets (c) $ 609,567 $ 440,874 (a) Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows. (b) Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows. (c) Includes additions arising from lease modifications.

Long Term Debt (Tables)

Long Term Debt (Tables)	9 Months Ended
	Oct. 29, 2022
Debt Disclosure [Abstract]
Long Term Debt	Long term debt consists of: (in thousands) October 29, January 29, October 30, 2022 2022 2021 Senior secured term loan facility (Term B-6 Loans), LIBOR (with a floor of 0.00 %) plus 2.00 %, matures on June 24, 2028 $ 944,178 $ 950,676 $ 952,841 Convertible senior notes, 2.25 %, matures on April 15, 2025 507,687 572,322 644,627 ABL senior secured revolving facility, SOFR plus spread based on average outstanding balance, matures on December 22, 2026 — — — Finance lease obligations 34,386 43,945 45,039 Unamortized deferred financing costs ( 8,160 ) ( 11,484 ) ( 13,638 ) Total debt 1,478,091 1,555,459 1,628,869 Less: current maturities ( 13,528 ) ( 14,357 ) ( 14,224 ) Long term debt, net of current maturities $ 1,464,563 $ 1,541,102 $ 1,614,645
Schedule of Components of Convertible Notes	The Convertible Notes consist of the following components as of the dates indicated: (in thousands) October 29, January 29, October 30, 2022 2022 2021 Principal $ 507,687 $ 572,322 $ 644,627 Unamortized deferred debt costs ( 6,644 ) ( 9,761 ) ( 11,845 ) Net carrying amount $ 501,043 $ 562,561 $ 632,782
Schedule of Interest Expense Related to Convertible Notes	Interest expense related to the Convertible Notes consists of the following as of the periods indicated: (in thousands) Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Coupon interest $ 2,854 $ 3,967 $ 8,711 $ 12,988 Amortization of deferred debt costs 647 941 2,065 2,948 Convertible Notes interest expense $ 3,501 $ 4,908 $ 10,776 $ 15,936

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Tables)	9 Months Ended
	Oct. 29, 2022
Fair Value of Company's Derivative Financial Instruments on Gross Basis as well as Classification	The table below presents the fair value of the Company’s derivative financial instruments on a gross basis as well as their classification on the Company’s Condensed Consolidated Balance Sheets: (in thousands) Fair Values of Derivative Instruments October 29, 2022 January 29, 2022 October 30, 2021 Derivatives Designated as Hedging Instruments Balance Fair Balance Fair Balance Fair Interest rate swap contracts Other assets $ 41,687 Other liabilities $ 10,968 Other liabilities $ 20,439
Summary of Unrealized Gains and Losses Deferred to Accumulated Other Comprehensive Income	The following table presents the unrealized gains and losses deferred to accumulated other comprehensive income resulting from the Company’s derivative financial instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Interest Rate Derivatives: October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Unrealized gains, before taxes $ 30,599 $ 8,936 $ 48,746 $ 3,096 Income tax benefit ( 8,197 ) ( 2,427 ) ( 13,053 ) ( 845 ) Unrealized gains, net of taxes $ 22,402 $ 6,509 $ 35,693 $ 2,251
Reclassification of Gains and Losses from Accumulated Other Comprehensive Income into Earnings	The following table presents information about the reclassification of gains and losses from accumulated other comprehensive income into earnings related to the Company’s derivative instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Component of Earnings: October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Interest expense $ 1,162 $ 4,096 $ 7,901 $ 10,519 Income tax benefit ( 311 ) ( 1,112 ) ( 2,129 ) ( 2,857 ) Net reclassification into earnings $ 851 $ 2,984 $ 5,772 $ 7,662
Derivatives Designated as Hedging Instruments
Outstanding Interest Rate Derivative in Qualifying Hedging Relationships	As of October 29, 2022, the Company had the following outstanding interest rate derivative that was designated as a cash flow hedge of interest rate risk: Interest Rate Derivative Number of Notional Aggregate Principal Amount Interest Swap Rate Maturity Date Interest rate swap contract One $ 450.0 million 2.19 % June 24, 2028

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 29, 2022	Oct. 29, 2022
Fair Value Disclosures [Abstract]
Fair Values of Financial Assets and Hierarchy of Level of Inputs		The fair values of the Company’s financial assets and the hierarchy of the level of inputs as of October 29, 2022, January 29, 2022 and October 30, 2021 are summarized below: (in thousands) Fair Value Measurements at October 29, January 29, October 30, 2022 2022 2021 Level 1 Cash equivalents (including restricted cash equivalents) $ 92,424 $ 701,638 $ 701,607
Fair Values of Financial Liabilities	The fair values of the Company’s financial liabilities are summarized below: (in thousands) October 29, 2022 January 29, 2022 October 30, 2021 Principal Fair Principal Fair Principal Fair Term B-6 Loans $ 949,397 $ 911,421 $ 956,608 $ 955,412 $ 959,011 $ 953,017 Convertible Notes 507,687 513,982 572,322 724,703 644,627 915,048 ABL Line of Credit (a) — — — — — — Total debt (b) $ 1,457,084 $ 1,425,403 $ 1,528,930 $ 1,680,115 $ 1,603,638 $ 1,868,065 (a) To the extent the Company has any outstanding borrowings under the ABL Line of Credit, the fair value would approximate its reported value, because the interest rate is variable and reflects current market rates, due to its short term nature. (b) The table above excludes finance lease obligations, debt discount and deferred debt costs.

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Oct. 29, 2022
Income Tax Disclosure [Abstract]
Net Deferred Taxes	Net deferred taxes are as follows: (in thousands) October 29, January 29, October 30, 2022 2022 2021 Deferred tax asset $ 3,643 $ 3,959 $ 4,119 Deferred tax liability 222,549 220,023 211,710 Net deferred tax liability $ 218,906 $ 216,064 $ 207,591

Net Income Per Share (Tables)

Net Income Per Share (Tables)	9 Months Ended
	Oct. 29, 2022
Earnings Per Share [Abstract]
Computation of Basic and Diluted Net Income per Share	The following table presents the computation of basic and diluted net income per share: (in thousands, except per share data) Three Months Ended Nine Months Ended October 29, October 30, October 29, October 30, 2022 2021 2022 2021 Basic net income per share Net income $ 16,783 $ 13,619 $ 44,923 $ 287,203 Weighted average number of common shares – basic 65,362 66,740 65,815 66,591 Net income per common share – basic $ 0.26 $ 0.20 $ 0.68 $ 4.31 Diluted net income per share Net income $ 16,783 $ 13,619 $ 44,923 $ 287,203 Shares for basic and diluted net income per share: Weighted average number of common shares – basic 65,362 66,740 65,815 66,591 Assumed exercise of stock options and vesting of restricted stock 142 577 243 666 Assumed conversion of convertible debt — 888 — 971 Weighted average number of common shares – diluted 65,504 68,205 66,058 68,228 Net income per common share – diluted $ 0.26 $ 0.20 $ 0.68 $ 4.21

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Oct. 29, 2022
Share-Based Payment Arrangement [Abstract]
Non-Cash Stock Compensation Expense	Non-cash stock compensation expense is as follows: (in thousands) Three Months Ended Nine Months Ended October 29, October 30, October 29, October 30, Type of Non-Cash Stock Compensation 2022 2021 2022 2021 Restricted stock and restricted stock unit grants (a) $ 9,736 $ 8,192 $ 28,519 $ 22,132 Stock option grants (a) 4,851 4,815 15,144 13,891 Performance stock unit grants (a) 2,730 4,290 7,532 17,333 Total (b) $ 17,317 $ 17,297 $ 51,195 $ 53,356 (a) Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income. (b) The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 29, 2022 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 3.2 million and $ 9.5 million, respectively . For the three and nine month periods ended October 30, 2021 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 3.1 million and $ 9.2 million, respectively .
Stock Option Transactions	Stock option transactions during the nine month period ended October 29, 2022 are summarized as follows: Number of Weighted Options outstanding, January 29, 2022 1,097,558 $ 181.17 Options granted 326,483 202.09 Options exercised (a) ( 65,745 ) 92.37 Options forfeited ( 30,453 ) 225.28 Options outstanding, October 29, 2022 1,327,843 $ 189.70 (a) Options exercised during the nine month period ended October 29, 2022 had a total intrinsic value of $ 6.4 million .
Stock Options Vested and Expected to Vest	The following table summarizes information about the stock options vested and expected to vest during the contractual term of such options as of October 29, 2022: Options Weighted Weighted Aggregate Options vested and expected to vest 1,327,843 7.0 $ 189.70 $ 9.4 Options exercisable 726,860 5.5 $ 161.97 $ 9.3
Weighted Average Assumptions Used to Estimate Fair Value of Each Stock Option Granted	The fair value of each stock option granted during the nine month period ended October 29, 2022 was estimated using the Black Scholes option pricing model using the following assumptions: Nine Months Ended October 29, 2022 Risk-free interest rate 1.13 % - 2.78 % Expected volatility 32 % - 34 % Expected life (years) 6.25 Contractual life (years) 10.0 Expected dividend yield 0 % Weighted average grant date fair value of options issued $ 75.64
Award Grant and Vesting Transactions	Restricted stock transactions during the nine month period ended October 29, 2022 are summarized as follows: Number of Weighted Non-vested awards outstanding, January 29, 2022 368,158 $ 233.00 Awards granted 247,768 201.96 Awards vested (a) ( 131,261 ) 205.03 Awards forfeited ( 20,429 ) 234.13 Non-vested awards outstanding, October 29, 2022 464,236 224.29 (a) Restricted stock awards vested during the nine month period ended October 29, 2022 had a total intrinsic value of $ 24.9 million .
Performance Stock Unit Transactions	Performance stock unit transactions during the nine month period ended October 29, 2022 are summarized as follows: Number of Weighted Non-vested awards outstanding, January 29, 2022 186,436 $ 215.90 Awards granted (a) 105,783 204.38 Awards vested (a) (b) ( 81,440 ) 173.84 Awards forfeited ( 10,094 ) 228.67 Non-vested awards outstanding, October 29, 2022 200,685 226.25 (a) Inclusive of awards distributed in connection with the final settlement of the performance-based stock awards granted in Fiscal 2019. (b) Performance-based stock awards vested during the nine month period ended October 29, 2022 had a total intrinsic value of $ 15.4 million.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Detail)	Oct. 29, 2022 Store
Summary Of Significant Accounting Policies [Line Items]
Number of stores operated	893

Company's Stockholders Equity (

Company's Stockholders Equity (Detail) - USD ($) $ in Thousands		3 Months Ended						9 Months Ended
		Oct. 29, 2022	Jul. 30, 2022	Apr. 30, 2022	Oct. 30, 2021	Jul. 31, 2021	May 01, 2021	Oct. 29, 2022	Oct. 30, 2021
Balance at beginning of period		$ 633,877	$ 716,156	$ 760,417	$ 675,695	$ 539,892	$ 464,754	$ 760,417	$ 464,754
Net income		16,783	11,966	16,174	13,619	102,554	171,030	$ 44,923	$ 287,203
Stock options exercised		121	1,230	4,721	2,709	12,811	16,089
Stock options exercised (in shares)	[1]							65,745
Shares used for tax withholding		(1,535)	(6,923)	(5,673)	(3,202)	(178)	(13,083)
Shares purchased as part of publicly announced program		$ (51,088)	(101,035)	(99,090)	$ (150,010)
Vesting of restricted shares, net of forfeitures of restricted shares		142,000			577,000			243,000	666,000
Stock based compensation		$ 17,317	17,173	16,705	$ 17,297	23,180	12,879
Shares issued to redeem convertible notes					$ 151,206
Shares issued to redeem convertible notes, (in shares)					888,000				971,000
Unrealized gains (losses) on interest rate derivative contracts, net of related taxes benefit		22,402	(6,769)	20,060	$ 6,509	(5,083)	825	$ 35,693	$ 2,251
Amount reclassified from accumulated other comprehensive income (loss) into earnings, net of related taxes		851	2,079	2,842	2,984	2,519	2,159	5,772	7,662
Balance at end of period		638,728	633,877	716,156	716,807	675,695	$ 539,892	638,728	716,807
Accounting Standards Update [Extensible List]							Accounting Standards Update (ASU) 2020-06
Cumulative-effect Adjustment
Balance at beginning of period						(114,761)
Balance at end of period							$ (114,761)
Common Stock
Balance at beginning of period		$ 7	$ 7	$ 7	$ 7	$ 7	$ 7	$ 7	$ 7
Balance at beginning of period (in shares)		81,907,528	81,800,820	81,677,315	81,041,969	80,897,050	80,661,453	81,677,315	80,661,453
Stock options exercised (in shares)		984	23,088	41,673	25,479	139,274	181,683
Vesting of restricted shares, net of forfeitures of restricted shares		25,383	83,620	81,832	24,437	5,645	53,914
Shares issued to redeem convertible notes, (in shares)					513,991
Balance at end of period		$ 7	$ 7	$ 7	$ 7	$ 7	$ 7	$ 7	$ 7
Balance at end of period (in shares)		81,933,895	81,907,528	81,800,820	81,605,876	81,041,969	80,897,050	81,933,895	81,605,876
Additional Paid-in Capital
Balance at beginning of period		$ 1,967,383	$ 1,948,980	$ 1,927,554	$ 1,742,874	$ 1,706,883	$ 1,809,831	$ 1,927,554	$ 1,809,831
Stock options exercised		121	1,230	4,721	2,709	12,811	16,089
Stock based compensation		17,317	17,173	16,705	17,297	23,180	12,879
Shares issued to redeem convertible notes					151,206
Balance at end of period		1,984,821	1,967,383	1,948,980	1,914,086	1,742,874	1,706,883	1,984,821	1,914,086
Additional Paid-in Capital | Cumulative-effect Adjustment
Balance at beginning of period						(131,916)
Balance at end of period							(131,916)
Accumulated (Deficit) Earnings
Balance at beginning of period		442,432	430,466	414,292	279,037	176,483	(11,702)	414,292	(11,702)
Net income		16,783	11,966	16,174	13,619	102,554	171,030
Balance at end of period		459,215	442,432	430,466	292,656	279,037	176,483	459,215	292,656
Accumulated (Deficit) Earnings | Cumulative-effect Adjustment
Balance at beginning of period						17,155
Balance at end of period							17,155
Accumulated Other Comprehensive (Loss) Income
Balance at beginning of period		13,771	18,461	(4,441)	(22,595)	(20,031)	(23,015)	(4,441)	(23,015)
Unrealized gains (losses) on interest rate derivative contracts, net of related taxes benefit		22,402	(6,769)	20,060	6,509	(5,083)	825
Amount reclassified from accumulated other comprehensive income (loss) into earnings, net of related taxes		851	2,079	2,842	2,984	2,519	2,159
Balance at end of period		37,024	13,771	18,461	(13,102)	(22,595)	(20,031)	37,024	(13,102)
Treasury Stock
Balance at beginning of period		$ (1,789,716)	$ (1,681,758)	$ (1,576,995)	$ (1,323,628)	$ (1,323,450)	$ (1,310,367)	$ (1,576,995)	$ (1,310,367)
Balance at beginning of period (in shares)		(16,361,061)	(15,728,755)	(15,185,760)	(14,317,493)	(14,316,890)	(14,275,122)	(15,185,760)	(14,275,122)
Shares used for tax withholding		$ 1,535	$ (6,923)	$ (5,673)	$ 3,202	$ (178)	$ (13,083)
Shares used for tax withholding (in shares)		10,968	(34,028)	(30,090)	10,898	(603)	(41,768)
Shares purchased as part of publicly announced program		$ 51,088	$ (101,035)	$ (99,090)	$ 150,010
Shares purchased as part of publicly announced program, (in shares)		370,599	(598,278)	(512,905)	512,363
Balance at end of period		$ (1,842,339)	$ (1,789,716)	$ (1,681,758)	$ (1,476,840)	$ (1,323,628)	$ (1,323,450)	$ (1,842,339)	$ (1,476,840)
Balance at end of period (in shares)		16,742,628	(16,361,061)	(15,728,755)	(14,840,754)	(14,317,493)	(14,316,890)	16,742,628	(14,840,754)
[1] Options exercised during the nine month period ended October 29, 2022 had a total intrinsic value of $ 6.4 million .

Company's Stockholders Equity_2

Company's Stockholders Equity (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended
	Oct. 29, 2022	Jul. 30, 2022	Apr. 30, 2022	Oct. 30, 2021	Jul. 31, 2021	May 01, 2021
Statement of Stockholders' Equity [Abstract]
Forfeited restricted shares			199	382	1,101	883
Unrealized gains (losses) on interest rate derivative contracts, Tax	$ 8.2	$ 2.6	$ 7.4	$ 2.4	$ 1.9	$ 0.3
Amount reclassified from accumulated other comprehensive loss into earnings on Interest Rate Cap Contracts, Tax	$ 0.3	$ 0.8	$ 1.1	$ 1.1	$ 0.9	$ 0.8

Lease Commitments - Additional

Lease Commitments - Additional Information (Detail) $ in Millions	9 Months Ended
	Oct. 29, 2022 USD ($) Store
Future Minimum Payments Receivable [Line Items]
Operating and finance leases, expiration period	30 years
Leases renewal option	5 years
Accrued lease liability | $	$ 394.5
Number of store committed to open or relocate but has not yet taken possession | Store	69

Future Lease Payments (Detail)

Future Lease Payments (Detail) - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 29, 2022	Oct. 30, 2021
Operating Leases
2022 (remainder)	$ 121,195
2023	554,017
2024	521,395
2025	487,318
2026	449,970
2027	411,946
Thereafter	1,359,967
Total future minimum lease payments	3,905,808
Amount representing interest	(686,178)
Total lease liabilities	3,219,630
Less: current portion of lease liabilities	(391,056)	$ (358,793)	$ (346,167)
Total long term lease liabilities	$ 2,828,574	2,539,420	2,560,663
Weighted average discount rate	4.80%
Weighted average remaining lease term (years)	8 years 2 months 12 days
Finance Leases
2022 (remainder)	$ 1,460
2023	5,906
2024	5,733
2025	3,604
2026	3,640
2027	3,640
Thereafter	24,233
Total future minimum lease payments	48,216
Amount representing interest	(13,830)
Total lease liabilities	34,386	$ 43,945	$ 45,039
Less: current portion of lease liabilities	(3,914)
Total long term lease liabilities	$ 30,472
Weighted average discount rate	6.10%
Weighted average remaining lease term (years)	12 years

Schedule of Net Lease Costs (De

Schedule of Net Lease Costs (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Finance lease cost:
Amortization of finance lease asset	[1]	$ 1,052	$ 1,140	$ 3,333	$ 3,414
Interest on lease liabilities	[2]	627	768	2,046	2,366
Operating lease cost	[3]	132,984	119,858	387,318	346,789
Variable lease cost	[3]	52,141	49,445	152,689	142,356
Total lease cost		186,804	171,211	545,386	494,925
Less all rental income	[4]	(1,507)	(1,386)	(4,195)	(4,015)
Total net rent expense	[5]	$ 185,297	$ 169,825	$ 541,191	$ 490,910
[1] Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income. Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income. Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income. Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income. Excludes an immaterial amount of short-term lease cost.

Schedule of Supplemental Cash F

Schedule of Supplemental Cash Flow Disclosures Related to Leases (Details) - USD ($) $ in Thousands		9 Months Ended
		Oct. 29, 2022	Oct. 30, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Cash payments arising from operating lease liabilities	[1]	$ 387,209	$ 381,006
Cash payments for the principal portion of finance lease liabilities	[2]	3,517	2,980
Cash payments for the interest portion of finance lease liabilities	[1]	2,046	2,366
Operating lease liabilities arising from obtaining right-of-use assets	[3]	$ 609,567	$ 440,874
[1] Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows. Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows. Includes additions arising from lease modifications.

Long-Term Debt (Detail)

Long-Term Debt (Detail) - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 29, 2022	Oct. 30, 2021
Debt Instrument [Line Items]
Finance lease obligations	$ 34,386	$ 43,945	$ 45,039
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Long term debt and capital lease obligations current and noncurrent	Long term debt and capital lease obligations current and noncurrent	Long term debt and capital lease obligations current and noncurrent
Unamortized deferred financing costs	$ (8,160)	$ (11,484)	$ (13,638)
Total debt	1,478,091	1,555,459	1,628,869
Less: current maturities	(13,528)	(14,357)	(14,224)
Long term debt, net of current maturities	1,464,563	1,541,102	1,614,645
Senior Secured Term B-6 Loans
Debt Instrument [Line Items]
Long Term Debt	944,178	950,676	952,841
Convertible Senior Notes
Debt Instrument [Line Items]
Long Term Debt	$ 507,687	$ 572,322	$ 644,627

Long-Term Debt (Parenthetical)

Long-Term Debt (Parenthetical) (Detail)		9 Months Ended		12 Months Ended
	Apr. 16, 2020	Oct. 29, 2022	Oct. 30, 2021	Jan. 29, 2022
Senior Secured Term B-6 Loans
Debt Instrument [Line Items]
Long-Term Debt, maturity date		Jun. 24, 2028	Jun. 24, 2028	Jun. 24, 2028
Convertible Senior Notes
Debt Instrument [Line Items]
Long-Term Debt, maturity date	Apr. 15, 2025	Apr. 15, 2025	Apr. 15, 2025	Apr. 15, 2025
Long-Term Debt, interest rate	2.25%	2.25%	2.25%	2.25%
Senior Secured Notes
Debt Instrument [Line Items]
Long-Term Debt, interest rate	6.25%
ABL senior secured revolving facility
Debt Instrument [Line Items]
Long-Term Debt, maturity date		Dec. 22, 2026	Dec. 22, 2026	Dec. 22, 2026
London Interbank Offered Rate Floor | Senior Secured Term B-6 Loans
Debt Instrument [Line Items]
Long-Term Debt, interest rate		0%	0%	0%
London Interbank Offered Rate (LIBOR) | Senior Secured Term B-6 Loans
Debt Instrument [Line Items]
Long-Term Debt, interest rate		2%	2%	2%

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Detail)

3 Months Ended

6 Months Ended

9 Months Ended

12 Months Ended

Jun. 24, 2021 USD ($)

Jun. 23, 2021

Jun. 11, 2021 USD ($)

Apr. 16, 2020 USD ($) $ / shares

Oct. 29, 2022 USD ($)

Apr. 30, 2022 USD ($)

Oct. 30, 2021 USD ($)

Jan. 29, 2022 USD ($) shares

Oct. 29, 2022 USD ($)

Oct. 30, 2021 USD ($) shares

Jan. 29, 2022 USD ($)

Jul. 20, 2022 USD ($)

Jul. 19, 2022 USD ($)

Jul. 31, 2021

Debt Instrument [Line Items]

Costs related to debt issuances and amendments

$ 89,000

$ 3,419,000

Loss on extinguishment of debt

(86,362,000)

$ (14,657,000)

$ (117,756,000)

Debt conversion, converted in to shares of common stock | shares

151,206

Deferred financing costs

$ 8,160,000

$ 13,638,000

$ 11,484,000

8,160,000

$ 13,638,000

$ 11,484,000

Line of Credit Facility, amount available

$ 850,000,000

$ 850,000,000

Senior Secured Term Loan Facilities

Debt Instrument [Line Items]

Borrowing, interest rate

5.10%

5.10%

2.10%

Convertible Senior Notes

Debt Instrument [Line Items]

Loss on extinguishment of debt

$ 14,700,000

$ 86,400,000

Debt instrument maturity date

Apr. 15, 2025

Apr. 15, 2025

Apr. 15, 2025

Apr. 15, 2025

Borrowing, interest rate

2.80%

2.80%

Long-Term Debt, face amount

$ 805,000,000

Long-Term Debt, interest rate

2.25%

2.25%

2.25%

2.25%

2.25%

2.25%

2.25%

Debt instrument frequency of periodic payments

semi-annually

Debt instrument, date of first required payment

Oct. 15, 2020

Debt instrument, conversion ratio

4.5418

Debt instrument, principal amount for conversion

$ 1,000

Debt conversion, aggregate principal amount of convertible debt

$ 64,600,000

$ 232,700,000

$ 232,700,000

Debt conversion, converted in to shares of common stock | shares

513,991

Debt conversion, converted instrument, in cash

$ 78,200,000

$ 199,800,000

Debt instrument, conversion price | $ / shares

$ 220.18

Debt instrument, conversion premium

32.50%

Share price | $ / shares

$ 166.17

Debt instrument, convertible, stock price trigger

130%

Debt instrument, redemption price, percentage

100%

Debt instrument repurchase percentage on conditional basis

100%

Convertible Senior Notes | Debt Component

Debt Instrument [Line Items]

Deferred financing costs

$ 6,644,000

$ 11,845,000

$ 9,761,000

$ 6,644,000

$ 11,845,000

$ 9,761,000

Senior Secured Notes

Debt Instrument [Line Items]

Loss on extinguishment of debt

30,200,000

Long-Term Debt, face amount

$ 300,000,000

$ 300,000,000

Long-Term Debt, interest rate

6.25%

Debt instrument frequency of periodic payments

semiannually

Debt instrument, date of first required payment

Oct. 15, 2020

Debt instrument, redemption price

$ 323,700,000

ABL senior secured revolving facility

Debt Instrument [Line Items]

Debt instrument maturity date

Dec. 22, 2026

Dec. 22, 2026

Dec. 22, 2026

Line of Credit Facility, maximum borrowing capacity

$ 650,000,000

Line of Credit Facility, amount available

541,000,000

$ 541,000,000

Line of Credit Facility, amount outstanding during period

$ 0

$ 0

$ 0

$ 0

Amended ABL senior secured revolving facility

Debt Instrument [Line Items]

Line of Credit Facility, maximum borrowing capacity

$ 900,000,000

Line of Credit Facility, interest rate description

The Amendment increased the aggregate principal amount of the commitments of its current asset-based lending facility (the ABL Line of Credit) from $650.0 million to $900.0 million and replaced the LIBOR-based interest rate benchmark provisions with interest rate benchmark provisions based on a term secured overnight financing rate (SOFR) or a daily SOFR rate (in the case of daily SOFR, available for borrowings up to $100 million, or up to the full amount of the commitments if the term SOFR rate is not available)

Adjusted London Interbank Offered Rate | Senior Secured Term Loan Facilities

Debt Instrument [Line Items]

Line of Credit Facility, interest rate

0%

Federal Funds Rate | Senior Secured Term Loan Facilities

Debt Instrument [Line Items]

Line of Credit Facility, interest rate

0.50%

One Month Adjusted London Interbank Offered Rate | Senior Secured Term Loan Facilities

Debt Instrument [Line Items]

Line of Credit Facility, interest rate

1%

Term Loan Facility

Debt Instrument [Line Items]

Costs related to debt issuances and amendments

$ 3,300,000

Debt instrument maturity date

Jun. 24, 2028

Nov. 17, 2024

Quarterly principal payments

$ 2,400,000

Term Loan Facility | Write Off Deferred Financing Costs

Debt Instrument [Line Items]

Loss on extinguishment of debt

$ (1,200,000)

Term Loan Facility | Prime Rate

Debt Instrument [Line Items]

Line of Credit Facility, interest rate

1%

0.75%

Term Loan Facility | London Interbank Offered Rate (LIBOR)

Debt Instrument [Line Items]

Line of Credit Facility, interest rate

2%

1.75%

Term Loan Facility | London Interbank Offered Rate Floor

Debt Instrument [Line Items]

Line of Credit Facility, interest rate

0%

Maximum | Secured Overnight Financing Rate (SOFR) | Amended ABL senior secured revolving facility

Debt Instrument [Line Items]

Line of Credit Facility, amount available

$ 100,000,000

Long-Term Debt - Schedule of Co

Long-Term Debt - Schedule of Components of Convertible Notes (Detail) - USD ($) $ in Thousands		Oct. 29, 2022	Jan. 29, 2022	Oct. 30, 2021
Debt Instrument [Line Items]
Principal	[1]	$ 1,457,084	$ 1,528,930	$ 1,603,638
Unamortized deferred financing costs		(8,160)	(11,484)	(13,638)
Convertible Senior Notes
Debt Instrument [Line Items]
Net carrying amount		507,687	572,322	644,627
Convertible Senior Notes | Debt Component
Debt Instrument [Line Items]
Principal		507,687	572,322	644,627
Unamortized deferred financing costs		(6,644)	(9,761)	(11,845)
Net carrying amount		$ 501,043	$ 562,561	$ 632,782
[1] The table above excludes finance lease obligations, debt discount and deferred debt costs.

Long-Term Debt - Schedule of In

Long-Term Debt - Schedule of Interest Expense Related to Convertible Notes (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Debt Instrument [Line Items]
Amortization of deferred financing costs			$ 2,731	$ 4,293
Convertible Senior Notes
Debt Instrument [Line Items]
Coupon interest	$ 2,854	$ 3,967	8,711	12,988
Amortization of deferred financing costs	647	941	2,065	2,948
Convertible Notes interest expense	$ 3,501	$ 4,908	$ 10,776	$ 15,936

Derivative Instruments And He_3

Derivative Instruments And Hedging Activities - Additional Information (Detail) $ in Millions			9 Months Ended
	Jun. 24, 2021 USD ($)	Dec. 17, 2018 USD ($)	Oct. 29, 2022 USD ($) Derivative
Interest Rate Cap Contracts
Derivative [Line Items]
Number of credit risk derivatives held | Derivative			1
Amounts reported in Accumulated Other Comprehensive income to be reclassified to interest expense, during the next twelve months			$ 4.8
Interest Rate Swap Contract | Cash Flow Hedging | Derivatives Designated as Hedging Instruments
Derivative [Line Items]
Notional aggregate principal amount	$ 450	$ 450	$ 450
Interest swap rate	2.19%	2.72%	2.19%
Amount of loss deferred for previous interest rate swap		$ 26.9
Interest rate swap liability fair value	$ 26.9
Maturity date	Jun. 24, 2028	Dec. 29, 2023	Jun. 24, 2028

Outstanding Interest Rate Deriv

Outstanding Interest Rate Derivative in Qualifying Hedging Relationships (Detail) - Cash Flow Hedging - Derivatives Designated as Hedging Instruments - Interest Rate Swap Contract $ in Millions			9 Months Ended
	Jun. 24, 2021 USD ($)	Dec. 17, 2018 USD ($)	Oct. 29, 2022 USD ($) Derivative
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of Instruments | Derivative			1
Notional aggregate principal amount | $	$ 450	$ 450	$ 450
Interest Swap Rate	2.19%	2.72%	2.19%
Maturity Date	Jun. 24, 2028	Dec. 29, 2023	Jun. 24, 2028

Derivative Instruments and He_4

Derivative Instruments and Hedging Activities (Detail) - Interest Rate Swap Contract - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 29, 2022	Oct. 30, 2021
Other Liabilities
Derivatives, Fair Value [Line Items]
Derivative Designated as Hedging Instruments Interest Rate Cap Contracts, Liability at Fair Value		$ 10,968
Other Assets
Derivatives, Fair Value [Line Items]
Derivative Designated as Hedging Instruments Interest Rate Cap Contracts, Liability at Fair Value	$ 41,687		$ 20,439

Summary of Unrealized Gains and

Summary of Unrealized Gains and Losses Deferred to Accumulated Other Comprehensive Income (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 29, 2022	Jul. 30, 2022	Apr. 30, 2022	Oct. 30, 2021	Jul. 31, 2021	May 01, 2021	Oct. 29, 2022	Oct. 30, 2021
Derivative Instruments Gain Loss [Line Items]
Income tax benefit	$ (8,200)	$ (2,600)	$ (7,400)	$ (2,400)	$ (1,900)	$ (300)
Unrealized gains, net of taxes	22,402	$ (6,769)	$ 20,060	6,509	$ (5,083)	$ 825	$ 35,693	$ 2,251
Derivatives Designated as Hedging Instruments | Interest Rate Derivatives
Derivative Instruments Gain Loss [Line Items]
Unrealized gains, before taxes	30,599			8,936			48,746	3,096
Income tax benefit	(8,197)			(2,427)			(13,053)	(845)
Unrealized gains, net of taxes	$ 22,402			$ 6,509			$ 35,693	$ 2,251

Reclassification of Gains and L

Reclassification of Gains and Losses from Accumulated Other Comprehensive Income into Earnings (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 29, 2022	Jul. 30, 2022	Apr. 30, 2022	Oct. 30, 2021	Jul. 31, 2021	May 01, 2021	Oct. 29, 2022	Oct. 30, 2021
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income On Derivatives [Line Items]
Interest expense	$ 17,412			$ 15,609			$ 47,454	$ 52,710
Income tax benefit	6,035			17,922			11,560	79,769
Net reclassification into earnings	(851)	$ (2,079)	$ (2,842)	(2,984)	$ (2,519)	$ (2,159)	(5,772)	(7,662)
Reclassification out of accumulated other comprehensive income | Derivatives Designated as Hedging Instruments | Accumulated net gain (loss) from cash flow hedges including portion attributable to noncontrolling interest | Interest Rate Cap Contracts
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income On Derivatives [Line Items]
Interest expense	1,162			4,096			7,901	10,519
Income tax benefit	(311)			(1,112)			(2,129)	(2,857)
Net reclassification into earnings	$ 851			$ 2,984			$ 5,772	$ 7,662

Fair Values of Financial Assets

Fair Values of Financial Assets and Hierarchy of Level of Inputs (Detail) - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 29, 2022	Oct. 30, 2021
Fair Value, Inputs, Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Cash equivalents (including restricted cash equivalents)	$ 92,424	$ 701,638	$ 701,607

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022 USD ($) Store	Oct. 30, 2021 USD ($) Store	Oct. 29, 2022 USD ($) Store	Oct. 30, 2021 USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset impairment carrying value related to right of use assets | $			$ 69,400	$ 13,900
Impairment charges - long-lived assets | $	$ 10,599	$ 1,488	$ 17,556	$ 3,235
Assets Impairments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Number of stores expected to sale	2		3
Impairment of store level assets, number of stores	8	4	8
Number of relocating stores			2

Fair Values of Financial Liabil

Fair Values of Financial Liabilities (Detail) - USD ($) $ in Thousands		Oct. 29, 2022	Jan. 29, 2022	Oct. 30, 2021	Oct. 31, 2020
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount	[1]	$ 1,457,084	$ 1,528,930	$ 1,603,638
Long-Term Debt, Fair Value	[1]	1,425,403	1,680,115	1,868,065
Term B-6 Loans
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount		949,397	956,608		$ 959,011
Long-Term Debt, Fair Value		911,421	955,412	953,017
Convertible Notes
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount		507,687	572,322	644,627
Long-Term Debt, Fair Value		$ 513,982	$ 724,703	$ 915,048
[1] The table above excludes finance lease obligations, debt discount and deferred debt costs.

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021	Jan. 29, 2022
Income Tax Disclosure [Line Items]
Income tax expense	$ 6,035	$ 17,922	$ 11,560	$ 79,769
Effective tax rate	26.40%	56.80%	20.50%	21.70%
Deferred tax asset for net operating loss	$ 14,600		$ 14,600
Tax credit carryforwards	7,800		7,800
Valuation allowances	10,600	$ 12,100	10,600	$ 12,100	$ 12,900
State and local jurisdiction
Income Tax Disclosure [Line Items]
Deferred tax asset for net operating loss	14,300		14,300
Tax credit carryforwards	7,100		$ 7,100
Tax credit expiration period			2023
State and local jurisdiction | Minimum
Income Tax Disclosure [Line Items]
Net operating losses subject to expiration year			2023
State and local jurisdiction | Maximum
Income Tax Disclosure [Line Items]
Net operating losses subject to expiration year			2041
Puerto Rico
Income Tax Disclosure [Line Items]
Deferred tax asset for net operating loss	300		$ 300
Net operating losses subject to expiration year			2025
Amount of alternative minimum tax credits	$ 700		$ 700
Alternative minimum tax credits, expiration life			indefinite life

Net Deferred Taxes (Detail)

Net Deferred Taxes (Detail) - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 29, 2022	Oct. 30, 2021
Income Tax Disclosure [Abstract]
Deferred tax asset	$ 3,643	$ 3,959	$ 4,119
Deferred tax liability	222,549	220,023	211,710
Net deferred tax liability	$ 218,906	$ 216,064	$ 207,591

Capital Stock - Additional Info

Capital Stock - Additional Information (Detail) - USD ($)			3 Months Ended						9 Months Ended
	Feb. 16, 2022	Aug. 18, 2021	Oct. 29, 2022	Jul. 30, 2022	Apr. 30, 2022	Oct. 30, 2021	Jul. 31, 2021	May 01, 2021	Oct. 29, 2022
Statement Equity Components [Line Items]
Shares Used for Tax Withholdings			$ 1,535,000	$ 6,923,000	$ 5,673,000	$ 3,202,000	$ 178,000	$ 13,083,000
2021 Stock Repurchase Program
Statement Equity Components [Line Items]
Stock repurchase programs, authorized amount	$ 500,000,000	$ 400,000,000
Stock repurchase programs, authorized execution month and year	2024-02	2023-08
Remaining authorized repurchase amount			398,800,000						$ 398,800,000
Common stock repurchased, shares									1,481,782
Common stock repurchased, value			$ 251,200,000						$ 251,200,000
Treasury Stock
Statement Equity Components [Line Items]
Shares Used for Tax Withholdings (in shares)									75,086
Shares Used for Tax Withholdings									$ 14,100,000

Computation of Basic and Dilute

Computation of Basic and Diluted Net Income per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Basic net income per share
Net income	$ 16,783	$ 13,619	$ 44,923	$ 287,203
Weighted average number of common shares – basic	65,362	66,740	65,815	66,591
Net income per common share - basic	$ 0.26	$ 0.20	$ 0.68	$ 4.31
Diluted net income per share
Net income	$ 16,783	$ 13,619	$ 44,923	$ 287,203
Weighted average number of common shares – basic	65,362	66,740	65,815	66,591
Assumed exercise of stock options and vesting of restricted stock	142	577	243	666
Assumed conversion of convertible debt		888		971
Weighted average number of common shares – diluted	65,504	68,205	66,058	68,228
Net income per common share - diluted	$ 0.26	$ 0.20	$ 0.68	$ 4.21

Net Income Per Share - Addition

Net Income Per Share - Additional Information (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive shares excluded from diluted net income per share	1,498,000	242,000	1,132,000	144,000
Conversion price of convertible notes excluded from computation of diluted earnings per share	$ 220.18		$ 220.18

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail)	9 Months Ended
	Oct. 29, 2022 shares
Performance Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Service-based awards, vesting period	3 years
Performance Stock Units | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Target award threshold range	200%
2022 Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for grant equity awards	6,287,228

Non-Cash Stock Compensation Exp

Non-Cash Stock Compensation Expense (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[1]	$ 17,317	$ 17,297	$ 51,195	$ 53,356
Restricted Stock and Restricted Stock Unit Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	9,736	8,192	28,519	22,132
Stock Option Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	4,851	4,815	15,144	13,891
Performance Stock Unit Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	$ 2,730	$ 4,290	$ 7,532	$ 17,333
[1] The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 29, 2022 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 3.2 million and $ 9.5 million, respectively . For the three and nine month periods ended October 30, 2021 , the tax benefit related to the Company’s non-cash stock compensation was approximately $ 3.1 million and $ 9.2 million, respectively . Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income.

Non-Cash Stock Compensation E_2

Non-Cash Stock Compensation Expense (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Share-Based Payment Arrangement [Abstract]
Non-Cash Stock Compensation tax benefit	$ 3.2	$ 3.1	$ 9.5	$ 9.2

Stock Option Transactions (Deta

Stock Option Transactions (Detail)	9 Months Ended
	Oct. 29, 2022 $ / shares shares
Number of Shares
Options Outstanding at Beginning of Period | shares	1,097,558
Options Granted | shares	326,483
Options Exercised | shares	(65,745)	[1]
Options Forfeited | shares	(30,453)
Options Outstanding at End of Period | shares	1,327,843
Weighted Average Exercise Price Per Share
Options Outstanding at Beginning of Period | $ / shares	$ 181.17
Options Granted | $ / shares	202.09
Options Exercised | $ / shares	92.37	[1]
Options Forfeited | $ / shares	225.28
Options Outstanding at End of Period | $ / shares	$ 189.70
[1] Options exercised during the nine month period ended October 29, 2022 had a total intrinsic value of $ 6.4 million .

Stock Option Transactions (Pare

Stock Option Transactions (Parenthetical) (Detail) $ in Millions	9 Months Ended
	Oct. 29, 2022 USD ($)
Share-Based Payment Arrangement [Abstract]
Share based compensation option exercised total intrinsic value	$ 6.4

Stock Options Vested and Expect

Stock Options Vested and Expected to Vest (Detail) $ / shares in Units, $ in Millions	9 Months Ended
	Oct. 29, 2022 USD ($) $ / shares shares
Share-Based Payment Arrangement [Abstract]
Vested and expected to vest, Options | shares	1,327,843
Vested and expected to vest, Weighted Average Remaining Contractual Life (Years)	7 years
Vested and expected to vest, Weighted Average Exercise Price | $ / shares	$ 189.70
Vested and expected to vest, Aggregate Intrinsic Value | $	$ 9.4
Options exercisable, Options | shares	726,860
Options exercisable, Weighted Average Remaining Contractual Life (Years)	5 years 6 months
Options exercisable, Weighted Average Exercise Price | $ / shares	$ 161.97
Options exercisable, Aggregate Intrinsic Value | $	$ 9.3

Weighted Average Assumptions Us

Weighted Average Assumptions Used to Estimate Fair Value of Stock Option (Detail)	9 Months Ended
	Oct. 29, 2022 $ / shares
Share-Based Payment Arrangement [Abstract]
Risk-free interest rate, minimum	1.13%
Risk-free interest rate, maximum	2.78%
Expected volatility, minimum	32%
Expected volatility, maximum	34%
Expected life (years)	6 years 3 months
Contractual life (years)	10 years
Expected dividend yield	0%
Weighted average grant date fair value of options issued	$ 75.64

Award Grant, Vested and Forfeit

Award Grant, Vested and Forfeiture Transactions (Detail) - Non Vested Restricted Stock	9 Months Ended
	Oct. 29, 2022 $ / shares shares
Number of Shares
Non-Vested Awards Outstanding at Beginning of Period | shares	368,158
Awards Granted | shares	247,768
Awards Vested | shares	(131,261)	[1]
Awards Forfeited | shares	(20,429)
Non-Vested Awards Outstanding at End of Period | shares	464,236
Weighted Average Grant Date Fair Value Per Award
Non-Vested Awards Outstanding at Beginning of Period | $ / shares	$ 233
Awards Granted | $ / shares	201.96
Awards Vested | $ / shares	205.03	[1]
Awards Forfeited | $ / shares	234.13
Non-Vested Awards Outstanding at End of Period | $ / shares	$ 224.29
[1] Restricted stock awards vested during the nine month period ended October 29, 2022 had a total intrinsic value of $ 24.9 million .

Award Grant, Vested and Forfe_2

Award Grant, Vested and Forfeiture Transactions (Parenthetical) (Detail) $ in Millions	9 Months Ended
	Oct. 29, 2022 USD ($)
Restricted Stock Issuances
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share based compensation awards vested total intrinsic value	$ 24.9

Performance Stock Units Transac

Performance Stock Units Transactions (Detail) - Performance Stock Units	9 Months Ended
	Oct. 29, 2022 $ / shares shares
Number of Shares
Non-Vested Awards Outstanding at Beginning of Period | shares	186,436
Awards Granted | shares	105,783	[1]
Awards Vested | shares	(81,440)	[1],[2]
Awards Forfeited | shares	(10,094)
Non-Vested Awards Outstanding at End of Period | shares	200,685
Weighted Average Grant Date Fair Value Per Award
Non-Vested Awards Outstanding at Beginning of Period | $ / shares	$ 215.90
Awards Granted | $ / shares	204.38	[1]
Awards Vested | $ / shares	173.84	[1],[2]
Awards Forfeited | $ / shares	228.67
Non-Vested Awards Outstanding at End of Period | $ / shares	$ 226.25
[1] Inclusive of awards distributed in connection with the final settlement of the performance-based stock awards granted in Fiscal 2019. Performance-based stock awards vested during the nine month period ended October 29, 2022 had a total intrinsic value of $ 15.4 million.

Performance Stock Units Trans_2

Performance Stock Units Transactions (Parenthetical) (Detail) $ in Millions	9 Months Ended
	Oct. 29, 2022 USD ($)
Performance Shares [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation awards vested total intrinsic value	$ 15.4

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)	Oct. 29, 2022	Jul. 19, 2022	Jan. 29, 2022	Oct. 30, 2021	Nov. 30, 2005
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	$ 50,000,000		$ 55,400,000	$ 59,000,000
Purchase commitments related to goods or services	1,157,000,000
Death benefits					$ 1,000,000
ABL senior secured revolving facility
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, maximum borrowing capacity		$ 650,000,000
Guarantee Performance Under Insurance And Utility Agreement
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	47,400,000		48,400,000	46,800,000
Merchandising Agreement
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	2,600,000		7,100,000	12,300,000
Letters of Credit | ABL senior secured revolving facility
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, maximum borrowing capacity	$ 850,000,000		$ 594,600,000	$ 541,000,000